ACR24 - JAK_TYK2
Rheumnow Podcast
00:00
Subgroup Analysis of Upatacitinib in Giant Cell Arteritis
This chapter analyzes abstract 1695 from ACR 2024, focusing on the subgroup analysis of patients with giant cell arteritis in the SELECT GCA trial. It highlights the favorable efficacy of upatacitinib compared to placebo across various demographics, emphasizing its implications for personalized treatment approaches in clinical practice.
Transcript
Play full episode
